Author Question: Kellett and Beall (1997) were treating a woman with suffering from posttraumatic stress disorder ... (Read 47 times)

penza

  • Hero Member
  • *****
  • Posts: 1,022
Kellett and Beall (1997) were treating a woman with suffering from posttraumatic stress disorder (PTSD) after an automobile accident.
 
  They obtained baseline measurements on frequency of nightmares, intensity of nightmares, and time to recover from a nightmare. They treated the woman, then obtained measurements of the same variables. This design illustrates
  a. an ABABAB design.
  b. a retrospective design.
  c. a withdrawal design.
  d. a multiple baseline study.

Question 2

If a researcher doing single-subject research wants to investigate several different behaviors, the design would be called
 
  a. a retrospective study.
  b. a case study.
  c. a multiple baseline study.
  d. an N of 1 randomized clinical trial.



parker125

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

d

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library